239 related articles for article (PubMed ID: 6609265)
21. [Adenosine deaminase activity in T-enriched and T-depleted preparations of human peripheral lymphocytes].
Nardiello S; Pizzella T; Russo M; Galanti B
Boll Soc Ital Biol Sper; 1981 May; 57(9):986-9. PubMed ID: 6974563
[TBL] [Abstract][Full Text] [Related]
22. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
[TBL] [Abstract][Full Text] [Related]
23. Selectively increased adenosine deaminase levels in T cells during typhoid fever.
Nardiello S; Russo M; Pizzella T; Galanti B
J Clin Lab Immunol; 1984 Jun; 14(2):103-5. PubMed ID: 6611417
[TBL] [Abstract][Full Text] [Related]
24. Cytokines regulate membrane adenosine deaminase on human activated lymphocytes.
Cordero OJ; Salgado FJ; Fernández-Alonso CM; Herrera C; Lluis C; Franco R; Nogueira M
J Leukoc Biol; 2001 Dec; 70(6):920-30. PubMed ID: 11739555
[TBL] [Abstract][Full Text] [Related]
25. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
26. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
27. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
Kefford RF; Fox RM
Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
29. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
[TBL] [Abstract][Full Text] [Related]
30. Action of 2'-deoxycoformycin on mitogen-induced lymphoproliferation in the neonatal period.
Romo A; Lorente F; Salazar V
Allergol Immunopathol (Madr); 1988; 16(4):243-7. PubMed ID: 3265855
[TBL] [Abstract][Full Text] [Related]
31. Activation of apoptosis in early mouse embryos by 2'-deoxyadenosine exposure.
Gao X; Blackburn MR; Knudsen TB
Teratology; 1994 Jan; 49(1):1-12. PubMed ID: 8171392
[TBL] [Abstract][Full Text] [Related]
32. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C
J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406
[TBL] [Abstract][Full Text] [Related]
33. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
34. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
Kubota M; Kamatani N; Daddona PE; Carson DA
Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
[TBL] [Abstract][Full Text] [Related]
35. Differences in the activity of adenosine deaminase and of purine nucleoside phosphorylase and in the sensitivity to deoxypurine nucleosides between subpopulations of mouse thymocytes.
Sidi Y; Umiel T; Trainin N; Pinkhas J; Sperling O
Thymus; 1982 May; 4(3):147-54. PubMed ID: 6810516
[TBL] [Abstract][Full Text] [Related]
36. Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes.
Scharenberg JG; Rijkers GT; Akkerman JW; Staal GE; Zegers BJ
Int J Immunopharmacol; 1990; 12(1):113-20. PubMed ID: 2303314
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase.
Wolos JA; Frondorf KA; Davis GF; Jarvi ET; McCarthy JR; Bowlin TL
J Immunol; 1993 Apr; 150(8 Pt 1):3264-73. PubMed ID: 8468468
[TBL] [Abstract][Full Text] [Related]
38. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
[TBL] [Abstract][Full Text] [Related]
39. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
40. Adenosine deaminase, nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase activity in normal lymphocyte subpopulations.
Davis S; Rambotti P
Anticancer Res; 1982; 2(3):125-8. PubMed ID: 6812486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
